News Novo Nordisk plans €432m investment in Irish GLP-1 plant Novo Nordisk invests in an Irish plant as it prepares for regulatory approvals of its Wegovy pill outside the US.
News FDA launches pilot programme to boost US manufacturing The FDA has started accepting requests to participate in its PreCheck pilot programme, promising rapid reviews of new manufacturing facilities.
News Lilly names Pennsylvania site for its latest US facility Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US - a $3.5bn facility in Pennsylvania.
News J&J jumps on the MFN pricing train Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.
News US vulnerable to China's API dominance, says report China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
